Abstract:Background Excess visceral adiposity is associated with increased risk of cardiometabolic disorders. Short‐term well‐controlled clinical trials suggest that regular avocado consumption favorably affects body weight, visceral adiposity, and satiety. Methods and Results The HAT Trial (Habitual Diet and Avocado Trial) was a multicenter, randomized, controlled parallel‐arm trial designed to test whether consuming 1 large avocado per day for 6 months in a diverse group of free‐living individuals (N=1008) with an elevated waist circumference compared with a habitual diet would decrease visceral adiposity as measured by magnetic resonance imaging. Secondary and additional end points related to risk factors associated with cardiometabolic disorders were assessed. The primary outcome, change in visceral adipose tissue volume during the intervention period, was not significantly different between the Avocado Supplemented and Habitual Diet Groups (estimated mean difference (0.017 L [−0.024 L, 0.058 L], P =0.405). No significant group differences were observed for the secondary outcomes of hepatic fat fraction, hsCRP (high‐sensitivity C‐reactive protein), and components of the metabolic syndrome. Of the additional outcome measures, modest but nominally significant reductions in total and low‐density lipoprotein cholesterol were observed in the Avocado Supplemented compared with the Habitual Diet Group. Changes in the other additional and post hoc measures (body weight, body mass index, insulin, very low‐density lipoprotein concentrations, and total cholesterol:high‐density lipoprotein cholesterol ratio) were similar between the 2 groups. Conclusions Addition of 1 avocado per day to the habitual diet for 6 months in free‐living individuals with elevated waist circumference did not reduce visceral adipose tissue volume and had minimal effect on risk factors associated with cardiometabolic disorders. Registration URL: https://clinicaltrials.gov; Unique identifier: NCT03528031. Nonstandard Abbreviations and Acronyms HAT Habitual Diet and Avocado Trial HEI Healthy Eating Index VAT visceral adipose tissue Clinical Perspective What Is New? In individuals with elevated waist circumference, consuming 1 large avocado per day (Avocado Supplemented Diet) for 6 months compared with habitual diets (Habitual Diet) had no significant effect on visceral adipose tissue volume. At the end of the 6‐month intervention period, changes in hepatic fat fraction, high‐sensitivity C‐reactive protein, components of the metabolic syndrome, body weight, body mass index, insulin, very low‐density lipoprotein concentrations, and total cholesterol:high‐density lipoprotein cholesterol ratio were similar between the Avocado Supplemented and Habitual Diet groups. What Are the Clinical Implications? Consistent with prior observations, a change in dietary patterns rather than a single food or nutrient may be necessary to achieve clinically significant improvements in visceral adiposity and other cardiometabolic risk factors. In the United States, ≈60% of adults have visceral adiposity, defined as a waist circumference of ≥40 inches for women and ≥35 inches for men. 1 , 2 Visceral adiposity is associated with elevated risk of type 2 diabetes, insulin resistance, systemic inflammation, cardiovascular disease, and all‐cause mortality. 3 , 4 , 5 , 6 To reduce the burden of these chronic disorders, strategies are needed to prevent the development of visceral adiposity. Independent of total caloric intake, diet quality has been reported to affect visceral adiposity. 7 , 8 , 9 One food of recent interest is avocados. Avocados are a good source of fiber and oleic acid, a monounsaturated fatty acid (MUFA). Observational data have linked avocado intake with lower rates of metabolic syndrome. 10 , 11 A National Health and Nutrition Examination Survey analysis (2001–2012) reported that avocado consumers weighed less (−3.4 kg) and had smaller waist circumferences (−1.2 cm) than -Abstract Truncated-

Associations between Metabolomic Biomarkers of Avocado Intake and Glycemia in the Multi-Ethnic Study of Atherosclerosis

Associations between avocado intake and measures of glucose and insulin homeostasis in Hispanic individuals with and without type 2 diabetes: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)

Avocado consumption and markers of inflammation: results from the Multi-Ethnic Study of Atherosclerosis (MESA)

The Impact of Avocado Intake on Anthropometric Measures among Hispanic/Latino Children and Adolescents: A Cluster Randomized Controlled Trial.

Abstract P108: Metabolic Profile of Diet Quality in the Multi-Ethnic Study of Atherosclerosis

Impact of daily avocado consumption on gut microbiota in adults with abdominal obesity: an ancillary study of HAT, a randomized controlled trial

Effect of daily avocado consumption for 6 mo compared with habitual diet on red blood cell fatty acid profiles and association with cardiometabolic risk factors in individuals with abdominal obesity: a randomized trial

Effect of Incorporating 1 Avocado Per Day Versus Habitual Diet on Visceral Adiposity: A Randomized Trial

Avocado intake and cardiometabolic risk factors in a representative survey of Australians: a secondary analysis of the 2011–2012 national nutrition and physical activity survey

The Design and Rationale of a Multi-Center Randomized Clinical Trial Comparing One Avocado Per Day to Usual Diet: the Habitual Diet and Avocado Trial (HAT)

Metabolomic Profile of the Healthy Eating Index-2015 in the Multiethnic Study of Atherosclerosis

Associations between dietary intake and glucose tolerance in clinical and metabolomics-based metabotypes

Hass Avocado Inclusion in a Weight-Loss Diet Supported Weight Loss and Altered Gut Microbiota: A 12-Week Randomized, Parallel-Controlled Trial

Association of Gut Microbiota-Related Metabolites and Type 2 Diabetes in Two Puerto Rican Cohorts

Human Metabolome Associates with Dietary Intake Habits among African Americans in the Atherosclerosis Risk in Communities Study

Abstract P498: Different Metabolomic Associations With Mediterranean Style Diet (MSD) Scores Between Individuals With Normoglycemia vs. Impaired Fasting Glucose (IFG) in the Multi-Ethnic Study of Atherosclerosis Transomic Precision Medicine Initiative (MESA-TOPMed) Data

Unlocking the Dietary Puzzle: How Macronutrient Intake Shapes the Relationship between Visfatin and Atherosclerosis in Type 2 Diabetes

Abstract 016: Artificially Sweetened Beverage Consumption, Plasma Metabolomics, And Risk Of Type 2 Diabetes Among US Adults

Abstract 17285: Metabolite-Derived Network Reveals Cluster of Acylcholine Metabolites Associated With Better Diet Quality and Lower Prevalence of Type 2 Diabetes: Findings From the Boston Puerto Rican Health Study

Investigating Gene-Diet Interactions Impacting the Association Between Macronutrient Intake and Glycemic Traits

Comparative associations of diabetes risk factors with five measures of hyperglycemia